Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01210235 · ClinicalTrials.gov registry record · NA

FLU-FIT Program at Kaiser Permanente Northern California

A NA study of Colorectal Cancer Screening, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
7,465
Enrollment target
1
Study location

NCT01210235: Completed NA study of Colorectal Cancer Screening, sponsored by University of California, San Francisco.

NCT01210235 is a NA study of Colorectal Cancer Screening that has completed, run by University of California, San Francisco. The registered enrollment target is 7,465 participants, above the 5,490-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01210235, a NA study of Colorectal Cancer Screening, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
7,465 participants
Enrollment target
1
Study location

Study Summary

The investigators overall goal is to develop, implement, test, and disseminate an intervention to increase colorectal cancer screening rates at Kaiser Permanente (KP) by providing home fecal immunochemical test kits (FIT) to eligible patients aged 50 and older who participate in annual influenza vaccination campaigns. The investigators hypothesis is that the FLU-FIT Program will be an effective method to increase colorectal cancer screening rates at Kaiser Permanente.

Primary Outcome

We will determine the proportion of patients aged 50-75 who are eligible for colorectal cancer screening at the time of their annual flu shot and become up to date with colorectal cancer screening 3 months later.

Interventions

  • BEHAVIORAL FLU-FIT Program

Study Locations (1)

California

  • Kaiser Permanente Northern California - Oakland

Trial Details

FieldValue
Enrollment Target 7,465 participants
Start Date 2009-10
Est. Completion 2012-04
Phase NA

What the finished NCT01210235 record still lists

NCT01210235 is an interventional study that assigns participants to a tested intervention. Its 7,465 participants enrollment target places it among the larger protocols in the corpus, above the 5,490-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (36% higher).

The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which FLU-FIT Program is the first listed.

NCT01210235 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01210235 about?

NCT01210235 is a clinical study titled "FLU-FIT Program at Kaiser Permanente Northern California". The investigators overall goal is to develop, implement, test, and disseminate an intervention to increase colorectal cancer screening rates at Kaiser Permanente (KP) by providing home fecal immunochemical test kits (FIT) to eligible patients aged 50 and older who participate in annual influenza vac...

What is the current status of trial NCT01210235?

This trial is currently completed. It is a NA study. The enrollment target is 7,465 participants. The study started on 2009-10. Estimated completion is 2012-04.

What conditions does trial NCT01210235 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening.

What interventions are being tested in trial NCT01210235?

The interventions under investigation include: FLU-FIT Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01210235?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01210235 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01210235's enrollment target sits among peer trials

7,465 2nd of 19 the highest of 19 other Colorectal Cancer Screening trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00439049 · 7,500 participants

    Substance Abuse Pre-Treatment Screening Study

  • NCT04809740 · 7,500 participants · NA

    Evaluating the Implementation and Impact of Navigator-delivered ePRO System

  • NCT05199701 · 7,500 participants · NA

    Prospective Case Collection Study for New Mammography Technologies

  • NCT06112418 · 7,500 participants · NA

    A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01210235, the US trial registry maintained by the National Library of Medicine. NCT01210235 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.